On March 5, 2024, Orgenesis Inc. closed the transaction. The company received $2,340,903 in funding pursuant to exemption provided under Regulation D. The transaction included participation from 46 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.609 USD | +5.00% | +17.12% | +21.63% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+21.63% | 20.74M | |
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it has received $2.340901 million in funding